echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New drugs for anti-Parkinson disease are on the market in China

    New drugs for anti-Parkinson disease are on the market in China

    • Last Update: 2020-07-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On March 9,, Bollinger Ingham announced in Shanghai that its new drug Pramipexole, Senfro, for the treatment of iexclusiveist Parkinson's disease symptoms and signs, had been approved for sale in ChinaThe drug is a selective non-baramine agonist that is used alone or in combination with levodopa throughout the entireofdiseasePraxo's chemical and receptor selectivity are different from bargos dopamine agonists such as Percot and Carmeprazole, and are very affinityive with dopamine D
    2family receptors, including D
    3and D
    2receptorsSome researchers believe that the drug's binding to dopamine D
    3receptors may be the biological basis for its antidepressant effectsA study called CALM-PD showed that in patients with early Parkinson's disease, using praxoas as an initial treatment significantly delayed the occurrence ofcomplications ofmovement, with significant differences from the levodopa group, where patients had good tolerance to the drugRecent studies have also shown that Plaxo can improve depressive symptoms and motivation in people with Parkinson's disease(reproduced from China Medical Daily)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.